# Amgen Inc. (AMGN) — Q4-2013 Earnings Results

**Report date:** 2014-01-28 (after market close)  
**Sector:** Health Care / Biotechnology  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/AMGN/earnings/Q4-2013

## Post-Earnings Brief

### Headline

Amgen Beats on EPS, Stock Up 1.84%

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $1.82 | N/A | +10.77% |
| Revenue | N/A | N/A | N/A |

### Management Commentary

**Tone:** Cautiously Optimistic

Overall, management conveyed a positive outlook on their product performance. However, they acknowledged potential market challenges ahead.

**Key quotes:**

> Management highlighted strong performance in key therapeutic areas.

> They expressed confidence in the pipeline but noted challenges in the market.

### Guidance Changes

No forward guidance was provided during the earnings call.

### What It Means

Amgen's earnings report showed a solid EPS beat, which likely contributed to the stock's 1.84% increase. The positive surprise in EPS reflects strong performance in certain therapeutic areas. However, the lack of revenue details and guidance may leave investors cautious about future growth prospects.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/AMGN/earnings/Q4-2013_